Turning Point Therapeutics to Participate in Goldman Sachs 41st Annual Global Healthcare Conference Webcast

NEXT STORY
SIGA Technologies Announces First International Delivery of Oral TPOXX®
PREV STORY
Iterum Therapeutics Announces Topline Results for a Phase 3 Clinical Trial of Oral and IV Sulopenem in Complicated Urinary Tract Infection
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Mental Health is Focus of New High-Potential Anti-Depression Project from MaRS Innovation and the Centre for Addiction and Mental Health

author_avatar
NASDAQ Market News

Relievant Medsystems Announces Publication of New INTRACEPT Trial Data Demonstrating Long-Term Relief for Chronic Low Back Pain 24 Months Post-Procedure

author_avatar
NASDAQ Market News

Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production Facility

Sanofi and Lonza Enter into a Strategic Partnership to Establish a Large-Scale Biologics Production ...

author_avatar
NASDAQ Market News